期刊文献+

抗抑郁剂治疗双相抑郁症引发转相的研究 被引量:6

Study of switching caused by antidepressant treatment for bipolar depressive disorder
下载PDF
导出
摘要 目的比较不同抗抑郁剂治疗双相抑郁症引发转相的差异。方法选择150例接受双作用抗抑郁剂(DAA)、5-羟色胺再摄取抑制剂(SSRI)或DAA联合SSRI抗抑郁治疗而出现躁狂、轻躁狂及快速循环情况的双相抑郁症患者进行研究,比较不同抗抑郁剂引发转相的差异。结果 150例双相抑郁症中,总体转相率为27.3%,转相与未转相患者的心境稳定剂的联合率比较差异有统计学意义(χ2=11.72,P<0.01)。DAA联合SSRI的转相率高于单用SSRI与DAA,差异有统计学意义(χ2=16.06,P<0.01;χ2=3.49,P<0.05);DAA的转相率高于SSRI,差异有统计学意义(χ2=4.65,P<0.01)。结论抗抑郁剂联合治疗的转相率高,而联合应用心境稳定剂有助于预防转相。 Objective To compare the difference of switching caused by antidepressant treatment for bipolar depressive disorder.Methods 150 patients with bipolar depressive disorder were selected and investigated.They were administrated with antidepressant treatment of dual action antidepressants(DAA),selective serotonin reuptake inhibitor(SSRI) or DAA combined with SSRI,and accompanied by mania,hypomania and rapid cycling status.The differences of switching caused by different antidepressants were compared.Results The overall switching rate was 27.3% among 150 patients with bipolar depressive disorder.Compared with the combination rates of mood stabilizing agents of switching and non-switching patients,the difference was statistically significant(χ2=11.72,P0.01).The switching rates of DAA combined with SSRI treatment were higher than those of SSRI or DAA treatment,with statistically significant difference(χ2=16.06,P0.01;χ2=3.49,P0.05),and the switching rates of DAA were higher than those of SSRI with statistically significant difference(χ2=4.65,P0.01).Conclusion Antidepressant combination treatment possesses high switching rate,and mood stabilizing agents contribute to preventing the switching.
作者 陆地 龚丽华
出处 《重庆医学》 CAS CSCD 北大核心 2011年第17期1687-1688,共2页 Chongqing medicine
关键词 双相情感障碍 抑郁症 抗抑郁药 色胺类 转相 bipolar disorder depressive disorder antidepressive agents tryptamines switching
  • 相关文献

参考文献12

  • 1Ronald C.Kessler,郭万军,曾卓谦,胡赤怡,刘肇瑞,黄悦勤,何燕玲,张明园,沈渔邨,李诚.世界精神卫生调查行动及其对中国精神障碍流行病学研究的提示[J].中国神经精神疾病杂志,2010,36(7):385-388. 被引量:38
  • 2金卫东,陈炯,邢葆平,王鹤秋,唐贤祥,徐乐平,李宁.抗抑郁药物引发转相的临床流行病学调查(1):转相率及其在不同类型抑郁症中的差异[J].药物流行病学杂志,2005,14(4):217-219. 被引量:24
  • 3金卫东,倪建良,王鹤秋.抗抑郁药引起躁狂:理论与实践问题[J].国外医学(精神病学分册),2004,31(2):103-106. 被引量:20
  • 4Boerlin H L,Gitlin MJ, Zoellner LA, et al. Bipolar depression and antidepressant-induced mania:a naturalistic study [J]. J Clin Psychiatry,1998,59(7) :374-379.
  • 5Barak Y,Kimhi R,Weizman R. Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients[J]. Int Clin Psyehopharmacol, 2000,15(1) :53-56.
  • 6Vieta E, Martinez-Aran A, Goikolea JM, et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers[J]. J Clin Psychiatry, 2002,63 (6):508-512.
  • 7金卫东,沈莹,陈虹.抗抑郁治疗的疗效评价及各类抗抑郁药的疗效比较[J].山东精神医学,2003,16(4):248-250. 被引量:31
  • 8Bottlender R, Rudolf D, Strauss A,et al. Antidepressantassociated maniform states in acute treatment of patients with bipolar-I depression [J]. Eur Arch Psychiatry Clin Neurosci, 1998,248 (6) : 296-300.
  • 9Peet M. Induction of mania with selective serotonin re -uptake inhibitors and tricyclic antidepressants[J]. Br J Psychiatry, 1994,164(4): 549-550.
  • 10Mundo E,Cattaneo E, Russo M, et al. Clinical variables related to antidepressant-induced mania in bipolar disorder[J]. J Affect Disord, 2006,92 (2/3) : 227-230.

二级参考文献67

  • 1金卫东,马永春,邢葆平,陈虹,童振华,陈震,唐贤祥.我国部分精神科医生关于抗抑郁治疗与转躁认识的初步调查[J].山东精神医学,2004,17(3):129-130. 被引量:10
  • 2Murray CJL,Lopez AD.The global burden of disease:A comprehensive assessment of mortality and disability from diseases,injuries,and risk factors in 1990 and projected to 2020[M].Cambridge,MA:Harvard University Press,1996:1-977.
  • 3Ormel J,Petukhova M,Chatterji S,et al.Disability and treatment of specific mental and physical disorders across the world:Results from the WHO World Mental Health Surveys[J].Br J Psychiatry,2008,192(5):368-375.
  • 4Cohen J.The global burden of disease study:A useful projection of future global health?[J].J Public Health Med,2000,22(4):518-524.
  • 5Canino GJ,Bird HR,Shrout PE,et al.The prevalence of specific psychiatric disorders in Puerto Rico[J].Arch Gen Psychiatry,1987,44(8):727-735.
  • 6Wells JE,Bushnell JA,Hornblow AR,et al.Christchurch psychiatric epidemiology study,part I:methodology and lifetime prevalence for specific psychiatric disorders[J].Aust N Z J Psychiatry,1989,23(3):315-326.
  • 7Wittchen HU,Essau CA,von Zerssen D,et al.Lifetime and six-month prevalence of mental disorders in the munich follow-up study[J].Eur Arch Psychiatry Clin Neurosci,1992,241(4):247-258.
  • 8Chen CN,Wong J,Lee N,et al.The Shatin community mental health survey in Hong Kong.II.major findings[J].Arch Gen Psychiatry,1993,50(2):125-133.
  • 9Kessler RC,McGonagle KA,Zhao S,et al.Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States:Results from the national comorbidity survey[J].Arch Gen Psychiatry,1994,51(1):8-19.
  • 10Wang PS,Demler O,Kessler RC.Adequacy of treatment for serious mental illness in the United States[J].Am J Public Health,2002,92(1):92-98.

共引文献129

同被引文献56

引证文献6

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部